throbber
Comparison of T Cell Receptor-Induced Proximal
`Signaling and Downstream Functions in Immortalized
`and Primary T Cells
`
`Rebekah R. Bartelt, Noemi Cruz-Orcutt, Michaela Collins, Jon C. D. Houtman*
`
`Department of Microbiology, University of Iowa, Iowa City, Iowa, United States of America
`
`Abstract
`
`Background: Human T cells play an important role in pathogen clearance, but their aberrant activation is also linked to
`numerous diseases. T cells are activated by the concurrent induction of the T cell receptor (TCR) and one or more
`costimulatory receptors. The characterization of signaling pathways induced by TCR and/or costimulatory receptor
`activation is critical, since these pathways are excellent targets for novel therapies for human disease. Although studies
`using human T cell
`lines have provided substantial
`insight into these signaling pathways, no comprehensive, direct
`comparison of these cell lines to activated peripheral blood T cells (APBTs) has been performed to validate their usefulness
`as a model of primary T cells.
`
`Methodology/PrincipalFindings: We used quantitative biochemical techniques to compare the activation of two widely
`used human T cell lines, Jurkat E6.1 and HuT78 T cells, to APBTs. We found that HuT78 cells were similar to APBTs in
`proximal TCR-mediated signaling events.
`In contrast, Jurkat E6.1 cells had significantly increased site-specific
`phosphorylation of Pyk2, PLCc1, Vav1, and Erk1/Erk2 and substantially more Ca2+ flux compared to HuT78 cells and
`APBTs. In part, these effects appear to be due to an overexpression of Itk in Jurkat E6.1 cells compared to HuT78 cells and
`APBTs. Both cell lines differ from APBTs in the expression and function of costimulatory receptors and in the range of
`cytokines and chemokines released upon TCR and costimulatory receptor activation.
`
`Conclusions/Significance:Both Jurkat E6.1 and HuT78 T cells had distinct similarities and differences compared to APBTs.
`Both cell lines have advantages and disadvantages, which must be taken into account when choosing them as a model T
`cell line.
`
`Citation: Bartelt RR, Cruz-Orcutt N, Collins M, Houtman JCD (2009) Comparison of T Cell Receptor-Induced Proximal Signaling and Downstream Functions in
`Immortalized and Primary T Cells. PLoS ONE 4(5): e5430. doi:10.1371/journal.pone.0005430
`
`Editor: Derya Unutmaz, New York University School of Medicine, United States of America
`
`Received January 23, 2009; Accepted April 9, 2009; Published May 4, 2009
`Copyright: ß 2009 Bartelt et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
`unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
`
`Funding: Start-up Funds from the Department of Microbiology at the University of Iowa to JCDH, American Heart Association-Scientist Development Grant
`Number 0830244N to JCDH (www.americanheart.org), American Cancer Society Seed Grant from the Holden Comprehensive Cancer Center at the University of
`Iowa to JCDH, McCord Graduate Fellowship for Wound Healing to RRB. The funders had no role in study design, data collection and analysis, decision to publish,
`or preparation of the manuscript.
`
`Competing Interests: The authors have declared that no competing interests exist.
`
`* E-mail: jon-houtman@uiowa.edu
`
`Introduction
`
`Human T cells control the extent and focus of the adaptive
`immune response to pathogens. T cells are activated by the
`interaction of the cell surface, multi-subunit T cell receptor (TCR)
`with an antigen-bound major histocompatibility complex present
`on an antigen presenting cell [1,2]. In addition to TCR induction,
`T cells also require an activating signal
`from one or more
`costimulatory receptors, such as CD28 or the a4b1 integrin VLA-
`4, to become fully active [1]. Costimulation is critical for the
`specificity of the immune response because it allows T cells to be
`activated only during acute infection. This enables the adaptive
`immune system to mount a response to foreign invaders while
`tolerating its own cells. The mistaken recognition of self leads to
`aberrant T cell activation, resulting in numerous human disease,
`such as autoimmune diseases, cardiovascular disease and allergies/
`asthma [3,4,5]. Signaling pathways
`that are activated by
`TCR and/or costimulatory receptors are good targets for the
`
`development of therapies to these diseases [4,5]. However, before
`effective therapies can be developed, we must
`first better
`understand the intracellular signaling that occurs when a T cell
`is activated.
`An initial event upon TCR activation is the induction of the Src
`family kinases Lck and Fyn, which then phosphorylate the
`immunoreceptor tyrosine-based activation motifs (ITAMs) present
`on several TCR subunits (Figure 1) [1]. The protein tyrosine
`kinase ZAP-70 is recruited to the phosphorylated ITAMs and
`activated upon phosphorylation of tyrosine 319 [1]. Activated Lck,
`Fyn, and ZAP-70 then phosphorylate multiple downstream
`substrates, including linker for activation of T cells (LAT) and
`the tyrosine kinase Pyk2 [6,7,8]. Pyk2 is a member of the Fak
`family of kinases and appears
`to control actin cytoskeletal
`rearrangements that are critical for T cell activation [6]. LAT is
`a hematopoietic-specific adaptor protein that mediates many
`downstream events
`following TCR stimulation. Upon TCR
`activation, LAT is phosphorylated on five conserved tyrosines,
`
`PLoS ONE | www.plosone.org
`
`1
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`Comparison of T Cell Lines
`
`Figure 1. Current model of proximal signaling pathways downstream of TCR activation. TCR activation leads to the induction of
`numerous tyrosine kinases and adaptor proteins. The activation of these signaling molecules leads to morphological changes and alterations in
`transcription that are vital for T cell activation and function. Proteins that are tyrosine phosphorylated upon TCR stimulation are identified with small
`black circles.
`doi:10.1371/journal.pone.0005430.g001
`
`which then bind to several SH2 domain-containing proteins, such
`as the related adaptor proteins Grb2, Grap, and Gads, as well as
`PLC-c1[8]. Once recruited to LAT, PLC-c1 is phosphorylated by
`the Tec family tyrosine kinase Itk at tyrosine 783. This leads to the
`increased ability of PLC-c1 to cleave phosphatidlyinositol
`(4,5)
`bisphosphate into inositol (1,4,5) trisphosphate, which is important
`for Ca2+
`influx, and diacylglycerol, which is important for protein
`kinase C activation [9].
`PLC-c1 and the Grb2 family of adaptor proteins all contain
`SH3 domains that mediate the recruitment of signaling proteins to
`LAT. Once such protein is SLP-76, an adaptor protein that is
`brought to the LAT complex via its interaction with the adaptor
`protein Gads and PLC-c1 (Figure 1) [10]. Upon TCR stimulation,
`SLP-76 is phosphorylated and both Vav1 and Itk bind to these
`phosphorylated tyrosines [10]. Vav1 is a guanine nucleotide
`exchange factor for Rac, a small GTPase that triggers cytoskeletal
`rearrangements downstream of TCR induction [11]. Vav1
`requires the presence of Itk to bind phosphorylated SLP-76,
`although it does not appear that Vav1 and Itk interact directly
`[12]. Similarly, Itk requires binding to phosphorylated SLP-76 to
`maintain its active conformation [13]. The end result of these
`interactions at the LAT complex is the induction of important
`
`downstream functions needed for T cell activation, such as Ca2+
`flux, Erk1/Erk2 activation,
`receptor upregulation and the
`induction of cytokine release.
`Much of our understanding of TCR-mediated signaling was
`discovered using two human T cell lines, the Jurkat E6.1 T cell
`and the HuT78 T cell. The original Jurkat cells were derived from
`a 14-year-old boy with T cell acute lymphoblastic leukemia (T-
`ALL). These cells are thymocytically derived with the character-
`istics of immature thymocytes. The Jurkat E6.1 subclone cell line
`was developed in the 1980s [14]. Sublines of Jurkat E6.1 cells have
`been isolated that are deficient
`in several TCR signaling
`molecules, including stable lines lacking the TCRb chain, Lck,
`LAT, SLP-76, ZAP-70, Vav1, or PLC-c1 [14]. These mutants
`have yielded much information and insight into the function of
`many peripheral TCR signaling molecules. The HuT78 T cell line
`is historically a very important cell line: the H9 subclone of HuT78
`T cells is the cell used to isolate HIV. HuT78 cells were derived
`from a Sezary syndrome patient, and are CD4+, mature,
`cutaneous, lymphoid T cells [15].
`Despite being highly useful for several reasons, such as mutant
`sublines, high rates of transfection, and ease of growth, Jurkat E6.1
`cells have several known abnormalities. These include deficiencies
`
`PLoS ONE | www.plosone.org
`
`2
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`in PTEN and SHIP, lipid phosphatases that regulate phospho-
`inositide-3 kinase (PI3K) function [16,17]. The lack of PTEN and
`SHIP leads to several irregularities including constitutive expres-
`sion of AKT, increased levels of phosphorylated phosphoinositide
`lipids, and the constitutive association of Itk with the plasma
`membrane [17,18]. HuT78 cells also have deficiencies; they have
`abnormal c-myc function and over express Bcl-xL, suggesting
`problems with anti-apoptotic pathways in these cells [19,20].
`Although all cell lines have inherent problems, there are many
`reasons to use cell
`lines as model systems for studying the
`activation and function of human T cells. Cell lines are useful
`because they offer an unlimited, genetically manipulatable and
`widely accessible supply of experimental material that can be
`stored long-term and grown at a low cost. Using continuous cell
`lines also reduces the human burden and ethical considerations of
`experimentation and substantially reduces donor
`to donor
`variation. It is important however, that the pros and cons of a
`specific cell
`line are appreciated to allow for interpretation of
`experiments using these cell
`lines. Surprisingly,
`there are no
`previous studies that directly compare TCR and/or costimulatory-
`mediated signaling and function in the human T cell
`lines to
`human activated peripheral blood T cells (APBTs). Therefore, we
`chose to compare the Jurkat E6.1 T cells and HuT78 T cells to
`APBTs in an effort to determine the conduciveness of using these
`T cell lines as a model for peripheral TCR signaling and function.
`We found that there was no noteworthy difference among the
`three cell
`lines when examining early signaling events such as
`ZAP-70, LAT, and SLP-76 phosphorylation. However, there were
`significant differences in downstream signaling events, costimula-
`tory receptor expression and activation and in the cytokines and
`chemokines released upon TCR induction. Advantages and
`disadvantages exist for both cell lines, which must be considered
`during the experimental design process.
`
`Results
`
`In order to compare proximal TCR-mediated signaling events
`in Jurkat E6.1 T cells, HuT78 T cells, and APBTs, equal cell
`numbers were activated with maximal doses of stimulatory TCR
`antibodies. The samples were then analyzed by immunoblotting
`using phosphospecific and pan antibodies to specific signaling
`molecules. We calculated the ratio of phosphorylated protein to
`total protein for each specific protein using quantified densities
`from the immunoblots. By using this method,
`the total
`phosphorylation per protein of a specific signaling molecule for
`each cell type was determined, regardless of the size of the cell or
`the concentration of protein present in each cell. Thus, the relative
`extent of activation of key signaling molecules was compared
`between each cell type.
`
`Jurkat E6.1 T cells, HuT78 T cells, and APBTs had
`significant differences in the phosphorylation of the
`tyrosine kinases ZAP-70, but not the adaptor proteins
`LAT and SLP-76
`Before the relative activation of critical signaling molecules can
`be assessed, the surface expression of the TCR ab chain in the
`various T cell
`lines must be determined. This information is
`needed because differences in the surface expression of the TCR
`ab chain in Jurkat E6.1 T cells, HuT78 T cells and APBTs may
`result in variations in receptor-mediated signaling events. To this
`end, the surface expression of the TCR ab chain in the Jurkat
`E6.1 T cells, HuT78 T cells and APBTs was examined by flow
`cytometry. The mean fluorescent intensity (MFI) of the TCR ab
`chain expression for three separate experiments was 78+/219 for
`
`Comparison of T Cell Lines
`
`Jurkat E6.1 T cells, 29+/29 for HuT78 T cells and 60+/28 for
`the APBTs (Figure 2 and data not shown). It was consistently
`observed that HuT78 T cells had significantly less TCR ab chain
`expression than Jurkat E6.1 T cells and APBTs, whereas there was
`no significant difference in the expression of TCR ab chain
`between the Jurkat E6.1 T cells and APBTs (Figure 2). Thus,
`theHuT78 T cells have significantly less TCR surface expression
`than the Jurkat E6.1 T cell and APBTs. However, whether this
`difference leads
`to alterations
`in the extent of
`intracellular
`signaling is unknown.
`Upon engagement of the TCR with a specific peptide-MHC
`complex,
`the tyrosine kinases ZAP-70 is phosphorylated and
`activated by the Src family kinases Lck and Fyn [1]. Therefore, it
`was of interest to determine if there were differences in the TCR-
`induced phosphorylation of ZAP-70 among Jurkat E6.1 T cells,
`HuT78 T cells and APBTs. Phosphorylation of ZAP-70 at tyrosine
`residue 319 is
`required for
`its activation and subsequent
`phosphorylation of
`the adaptor molecules LAT and SLP-76
`[21,22]. The phosphorylation of this tyrosine is an excellent read-
`out for enzymatically active ZAP-70. As seen in Figure 3, the
`relative levels of
`tyrosine 319 phosphorylation were similar
`between HuT78 T cells and APBTs. However,
`there was a
`significant and reproducible 2–3 fold decrease in the site-specific
`phosphorylation of ZAP-70 in Jurkat E6.1 T cells (Figure 3B). This
`suggests that Jurkat E6.1 T cells have reduced levels of TCR-
`induced ZAP-70 activation and potentially have altered down-
`stream signaling.
`We next examined the phosphorylation of signaling proteins
`downstream of ZAP-70 to see if the diminished phosphorylation of
`this important early kinase translated to later differences in TCR-
`mediated signaling. ZAP-70 is the known kinase for the adaptor
`proteins LAT and SLP-76 [23]. The phosphorylation of LAT at
`tyrosine 191 is essential
`for the formation of multi-protein
`signaling complexes that
`transmit
`the signal
`from the TCR
`complex to downstream effectors [7,8]. When the relative levels of
`LAT tyrosine 191 phosphorylation were examined, no differences
`
`Figure 2. HuT78 T cells have less TCR surface expression than
`Jurkat E6.1 T cells and APBTs. The surface expression of the TCR a/b
`chain on Jurkat E6.1 T cells, HuT78 T cells, and APBTs was assessed by
`flow cytometry. A representative plot of the TCR surface expression of
`these cell lines is shown. The isotype control for each cell had a mean
`fluorescent intensity of ,8. The experiment was repeated three times.
`doi:10.1371/journal.pone.0005430.g002
`
`PLoS ONE | www.plosone.org
`
`3
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`Comparison of T Cell Lines
`
`Figure 3. Jurkat E6.1 T cells exhibit decreased ZAP-70 Y319 phosphorylation compared to HuT78 T cells and APBTs. (A) Three
`samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific
`phosphorylation and expression of ZAP-70 was assessed by immunoblotting using ZAP-70 pY319 (top) and pan-ZAP-70 (bottom) antibodies. (B) The
`immunoblots were analyzed by densitometry and the ratio of the intensity of the phosphospecific ZAP-70 band to the pan-ZAP-70 band for each cell
`line was averaged. Letters represents significant differences of p,0.05.
`doi:10.1371/journal.pone.0005430.g003
`
`were observed between Jurkat E6.1 and APBT samples or between
`HuT78 and APBT samples (Figure 4A and 4B). However, there
`was a small but significant difference in the phosphorylation of
`LAT tyrosine 191 between Jurkat E6.1 and HuT78 T cell lines
`(Figure 4A and 4B). These data show that the phosphorylation of
`LAT is not substantially different among the cell lines, indicating
`the binding capacity of LAT in each cell is similar.
`Another important adaptor protein for functions downstream of
`TCR activation is SLP-76. This protein is phosphorylated on three
`tyrosine residues, including tyrosine 128. Phosphorylated SLP-76
`is essential
`for bringing Vav1 and Itk to the LAT signaling
`complex [10], which is vital for linking proximal TCR signaling to
`events such as calcium influx and actin cytoskeletal rearrange-
`ment. As seen for LAT, no difference was seen among the two cell
`lines and APBTs in the phosphorylation of SLP-76 tyrosine 128
`(Figure 4C and 4D), suggesting that SLP-76 has a similar signaling
`capacity in each type of cell. Together, these data indicate that the
`reduced levels of TCR a/b chain surface expression in the HuT78
`T cells compared to other T cell lines and the decrease in ZAP-70
`phosphorylation observed in Jurkat E6.1 T cells compared to
`HuT78 T cells and APBTs does not translate into differences in
`the activation of signaling proteins immediately downstream of
`ZAP-70.
`
`Jurkat E6.1 T cells have hyperphosphorylated PLC-c1 and
`exhibited exaggerated Ca2+ signaling compared to
`HuT78 T cells and APBTs
`Next, differences in several important signaling events down-
`stream of LAT and SLP-76 were characterized in Jurkat E6.1 T
`cells, HuT78 T cells, and APBTs. PLC-c1 activation is important
`for both intracellular calcium flux and protein kinase C activation
`[1,8]. Tyrosine 783 on PLC-c1 is phosphorylated by the Tec
`for PLC-c1 activation and
`family kinase Itk and is essential
`
`enzymatic function [13,24,25]. Therefore, the phosphorylation of
`PLC-c1 tyrosine 783 was characterized to determine if there was a
`difference in the phosphorylation of this important residue among
`the T cell lines. Surprisingly, a 10-fold increase in the relative
`phosphorylation of PLC-c1 tyrosine 783 was observed in the
`Jurkat E6.1 T cell
`line, compared to the HuT78 T cells and
`APBTs (Figure 5A and 5B). In contrast, no difference in the site-
`specific phosphorylation of PLC-c1 was
`found between the
`HuT78 T cells and APBTs (Figure 5A and 5B). This suggests
`that PLCc1 is substantially more activated in Jurkat E6.1 T cells
`compared to HuT78 T cells or APBTs.
`The phosphorylation of tyrosine 775 on PLCc1 is also known to
`be critical for TCR-induced Ca2+
`influx and transcription factor
`activation [26]. Therefore, we examined whether the TCR-
`mediated phosphorylation of this site is also increased in Jurkat
`E6.1 T cells compared to other T cell lines. Interestingly, Jurkat
`E6.1 T cells and APBTs had no detectable difference in the TCR-
`induced phosphorylation of tyrosine 775 on PLCc1 (Figure 5C
`and 5D). In contrast, HuT78 T cells had significantly less
`phosphorylation of this site compared to both Jurkat E6.1 T cells
`and APBTs
`(Figure 5C and 5D). This
`indicates
`that
`the
`phosphorylation of tyrosines 775 and 783 on PLCc1, which are
`both required for optimal TCR-induced function of this protein,
`may be differentially regulated.
`The observation that PLCc1 Y783 is hyperphosphorylated in
`Jurkat E6.1 T cells compared to HuT78 T cells and APBTs lead us
`to further examine the kinetics of PLC-c1 phosphorylation. This
`was done in order to determine if
`the large differences in
`phosphorylation were seen not only in the amount of TCR-
`induced phosphorylation of PLC-c1 tyrosine 783 at a single
`timepoint, but also in the timing and duration of this phosphor-
`ylation event. A substantial difference was seen in the kinetics of
`phosphorylation of PLC-c1 tyrosine 783 between Jurkat E6.1 T
`
`PLoS ONE | www.plosone.org
`
`4
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`Comparison of T Cell Lines
`
`Figure 4. Jurkat E6.1 T cells, HuT78 T cells, and APBTs have similar levels of LAT and SLP-76 phosphorylation. (A) Three samples of
`Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation
`and expression of LAT was assessed by immunoblotting using LAT pY191 (top) and pan-LAT (bottom) antibodies. (B) The immunoblots were analyzed
`by densitometry and the ratio of the intensity of the phosphospecific LAT band to the pan-LAT band for each cell line was averaged. Letters
`represents significant differences of p,0.01. (C) Three samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular
`proteins were separated by SDS-PAGE. The site-specific phosphorylation and expression of SLP-76 was assessed by immunoblotting using SLP-76
`pY128 (top) and pan-SLP-76 (bottom) antibodies. (D) The immunoblots were analyzed by densitometry and the ratio of the intensity of the
`phosphospecific SLP-76 band to the pan-SLP-76 band for each cell line was averaged. There were no significant differences between cell lines and
`p.0.25.
`doi:10.1371/journal.pone.0005430.g004
`
`cells, and HuT78 T cells. HuT78 T cells reached maximal
`phosphorylation at 1 minute post-TCR stimulation, followed by a
`steady decrease in phosphorylation over 30 minutes (Figure 6A).
`APBTs and HuT78 T cells had similar TCR-induced phosphor-
`ylation kinetics of PLC-c1 Y783 (data not shown). In contrast, the
`Jurkat E6.1 T cell
`line reached maximal phosphorylation at
`2 minutes and the phosphorylation of tyrosine 783 decreased only
`
`slightly over the course of 30 minutes (Figure 6A). This indicates
`that Jurkat E6.1 T cell have not only greater relative PLC-c1
`tyrosine 783 phosphorylation than HuT78 T cells and APBTs, but
`that they also sustain that level of hyperphosphorylation for a
`much longer time.
`The TCR-induced influx of Ca2+
`into human T cells is
`controlled by PLC-c1 activation. The influx of Ca2+
`is important
`
`PLoS ONE | www.plosone.org
`
`5
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`Comparison of T Cell Lines
`
`Figure 5. T cell lines have differences in PLCc1 phosphorylation. (A) Three samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were
`stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation and expression of PLCc1 was assessed by
`immunoblotting using PLCc1 pY783 (top) and pan-PLCc1 (bottom) antibodies. (B) The immunoblots were analyzed by densitometry and the ratio of
`the intensity of the phosphospecific PLC-c1 band to the pan-PLC-c1 band for each cell line was averaged. Letters represents significant differences of
`p,0.0005. (C) Three samples of Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE.
`The site-specific phosphorylation and expression of PLCc1 was assessed by immunoblotting using PLCc1 pY775 (top) and pan-PLCc1 (bottom)
`antibodies. (D) The immunoblots were analyzed by densitometry and the ratio of the intensity of the phosphospecific PLC-c1 band to the pan-PLC-c1
`band for each cell line was averaged. Letters represents significant differences of p,0.03.
`doi:10.1371/journal.pone.0005430.g005
`
`for many effectors functions in T cells, including NFAT activation
`and cytokine and chemokine production [1,27]. Due to its
`importance in downstream T cell functions, we examined whether
`the hyperphosphorylation of PLC-c1 in Jurkat E6.1 T cells lead to
`alterations in the levels of TCR-induced Ca2+
`influx in the T cell
`lines and APBTs. To this end, we utilized a quantitative, real-time
`measurement method for intracellular Ca2+
`developed by Tsien
`
`and coworkers [28]. Using this method, it was observed that both
`showed TCR inducible Ca2+
`influx
`cell
`lines and APBTs
`(Figure 6B). Jurkat E6.1 T cells exhibited approximately 7–10-
`fold higher Ca2+
`flux immediately following stimulation than
`HuT78 T cells or APBTs, as well as a higher level and longer time
`of sustained Ca2+
`(Figure 6B). HuT78 T cells also showed higher
`levels of initial Ca2+
`signaling than APBTs, although they returned
`
`PLoS ONE | www.plosone.org
`
`6
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`Comparison of T Cell Lines
`
`Figure 6. Jurkat E6.1 T cells have increased PLCc1 function compared to HuT78 T cells and APBTs. (A) Jurkat E6.1 T cells and HuT78 T
`cells were stimulated over a 309 time course and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation and expression
`of PLCc1 and the expression of actin was assessed by immunoblotting using PLCc1 pY783 (top) and pan-PLCc1 (bottom) antibodies. (B) TCR-induced
`calcium flux was measured quantitatively as described above. Traces for Jurkat E6.1 T cells, HuT78 T cells and APBTs are shown.
`doi:10.1371/journal.pone.0005430.g006
`
`to similar levels as APBTs much more quickly than Jurkat E6.1
`T cells (Figure 6B). These data indicate that
`the increased
`phosphorylation of PLC-c1 tyrosine 783 in Jurkat E6.1 T cells also
`translated into an amplification in Ca2+
`flux, as compared to
`HuT78 and APBT cells.
`
`Jurkat E6.1 T cells have hyperphosphorylated Pyk2 and
`Vav1 compared to HuT78 T cells and APBTs
`The intracellular tyrosine kinase Pyk2 is critical for integrating
`receptor mediated signals that control the rearrangement of the
`actin cytoskeleton [6]. The levels of the enzymatic activity of Pyk2
`is controlled by the phosphorylation of
`tyrosine 580 in the
`activation loop of
`the kinase domain [6]. Therefore,
`the
`phosphorylation of this site can be used as a marker for the
`induction of the kinase activity of Pyk2. To investigate the relative
`activation of Pyk2 in Jurkat E6.1 T cells, HuT78 T cells, and
`APBTs, the cells were stimulated for 1 minute (Jurkat E6.1 cells) or
`30 seconds (HuT78 T cells and APBTs), which corresponded to
`the maximal activation time of Pyk2 in these cell types (M. Collins
`and J.C.D. Houtman, unpublished results). Interestingly,
`the
`relative level of Pyk2 tyrosine 580 phosphorylation was signifi-
`cantly different between Jurkat E6.1 T cells, HuT78 T cells and
`APBTs, with Jurkat E6.1 T cells having the highest relative level of
`Pyk2 tyrosine 580 phosphorylation and HuT78 T cells having the
`lowest (Figure 7A and Figure 5B). These experiments show that
`the enzymatic activity of Pyk2 is different in the individual T cell
`lines, suggesting that there are differences in the ability of the TCR
`to control the actin cytoskeleton between Jurkat E6.1 T cells,
`HuT78 T cells and APBTs.
`
`the
`is
`these differences
`One potential mechanism for
`differential expression of PTP-PEST, a tyrosine phosphatase
`known to dephosphorylate Pyk2 in T cells [29]. To investigate
`this possibility, the expression of PTP-PEST in the three T cell
`lines was characterized. Unfortunately, the expression of PTP-
`PEST was not detectable in cell
`lysates
`(data not
`shown).
`Therefore, PTP-PEST was immunoprecipitated from unstimu-
`lated Jurkat E6.1 T cells, HuT78 T cells and APBTs. As seen in
`Figure 7C, HuT78 T cells express PTP-PEST, whereas Jurkat
`E6.1 T cells and APBTs have no detectable expression of this
`phosphatase. These results agree with a recent study that also
`observed the Jurkat E6.1 T cells and APBTs do not express PTP-
`PEST [30]. These data suggest that the expression of PTP-PEST
`in HuT78 T cells results in reduced levels of Pyk2 phosphory-
`lation compared to APBTs. In contrast, the significant differences
`in the TCR-induced phosphorylation of Pyk2 in Jurkat E6.1 T
`cells and APBTs are not due to differential expression of this
`phosphatase.
`Vav1 is a guanine nucleotide exchange factor for the small
`GTPase Rac1 and is important
`for receptor-mediated actin
`cytoskeletal rearrangement in human T cells [11]. An obligate step
`in the enzymatic activation of Vav1 is the phosphorylation of
`tyrosine 174 [11]. In contrast to Pyk2, Vav1 tyrosine 174 had a
`moderate 2-fold hyperphosphorylation in Jurkat E6.1 T cells
`compared to both HuT78 T cells and APBTs (Figure 8A and
`Figure 6B). These data suggest that Vav1 is hyperactivated in
`Jurkat E6.1 T cells, which, in conjunction with the hyperpho-
`sphorylation of Pyk2, indicates a potential distortion of cytoskeletal
`rearrangement in these cells.
`
`PLoS ONE | www.plosone.org
`
`7
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`Comparison of T Cell Lines
`
`Figure 7. Jurkat E6.1 T cells, HuT78 T cells, and APBTs have different levels of Pyk2 Y580 phosphorylation. (A) Three samples of Jurkat
`E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation and
`expression of Pyk2 was assessed by immunoblotting using Pyk2 pY580 (top) and pan-Pyk2 (bottom) antibodies. (B) The immunoblots were analyzed
`by densitometry and the ratio of the intensity of the phosphospecific Pyk2 band to the pan-Pyk2 band for each cell line was averaged. Letters
`represents significant differences of p,0.05. (C) PTP-PEST was immunoprecipitated for Jurkat E6.1 T cells, HuT78 T cells and APBTs. The expression of
`PTP-PEST in the different T cells was assessed by immunoblotting.
`doi:10.1371/journal.pone.0005430.g007
`
`Itk, the common link between PLC-c1 and Vav1, has
`increased expression in Jurkat E6.1 T cells
`The hyperphosphorylation of both Vav1 and PLC-c1 at
`important tyrosine residues, as well as exaggerated Ca2+
`flux, in
`Jurkat E6.1 T cells led us to examine Itk, the common link among
`these events. Itk requires Vav1 to bind SLP-76, an event necessary
`for Itk to phosphorylate PLC-c1 Y783 [12]. Phosphorylation of
`tyrosine residue 511 is required for the activation of Itk [31],
`therefore the phosphorylation of this site serves as a marker for the
`induction of Itk kinase activity. Unfortunately, we were unable to
`directly detect any TCR-induced site-specific phosphorylation of
`Itk in stimulated T cell lysates (data not shown). Consequently, Itk
`immunoprecipitations were performed to examine differences in
`the phosphorylation of Itk tyrosine 511. Interestingly, there was
`observable TCR-induced phosphorylation of Itk tyrosine 511in
`Jurkat E6.1 T cells, but little detectable phosphorylation of this site
`
`in HuT78 T cells and APBTs (Figure 9A and Figure 7B). In
`addition, there was an increase in the amount of immunoprecip-
`itated Itk in Jurkat E6.1 T cells compared to HuT78 T cells and
`APBTs (Figure 9A), suggesting Jurkat E6.1 cells have increased
`expression of Itk. To more directly compare expression of Itk in
`the T cell lines, the levels of Itk in an equal cell number of Jurkat
`E6.1 T cells and HuT78 T cells, and APBTs was measured by
`immunoblotting. Jurkat E6.1 T cells had at least a 2-fold greater
`Itk expression than HuT78 T cells (Figure 9C). Jurkat E6.1 T cells
`from different laboratories had differences in the relative levels of
`Itk, with most having increased levels of this protein. This suggests
`that there are variations in the relative levels of signaling proteins
`in individual sublines of the Jurkat E6.1 T cells. Collectively, these
`data indicate that the increased expression of Itk in Jurkat E6.1 T
`cells compared to HuT78 T cells and APBTs is linked to
`exaggerated TCR-mediated signaling.
`
`PLoS ONE | www.plosone.org
`
`8
`
`May 2009 | Volume 4 |
`
`Issue 5 | e5430
`
`UPenn Ex. 2075
`Miltenyi v. UPenn
`IPR2022-00855
`
`

`

`Comparison of T Cell Lines
`
`Figure 8. Jurkat E6.1 T cells exhibit hyperphosphorylated of Vav1 Y174 compared to HuT78 T cells and APBTs. (A) Three samples of
`Jurkat E6.1 T cells, HuT78 T cells, and APBTs were stimulated and the cellular proteins were separated by SDS-PAGE. The site-specific phosphorylation
`and expression of Vav1 was assessed by immunoblotting using Vav1 pY174 (top) and pan-Vav1 (bottom) antibodies. (B) The immunoblots were
`analyzed by densitometry and the ratio of the intensity of the phosphospecific Vav1 band to the pan-Vav1 band for each cell line was averaged.
`Letters represents significant differences of p,0.005.
`doi:10.1371/journal.pone.0005430.g008
`
`Jurkat E6.1 T cells have hyperphosphorylated Erk1 and
`Erk2 compared to HuT78 T cells and APBTs
`for the
`The MAP kinases Erk1 and Erk2 are important
`regulation of the expression and function of the transcription
`factor AP-1 [1]. The activation of these kinases is downstream of
`LAT phosphorylation, Vav1 activation, and Ca2+
`influx [1]. The
`phosphorylation of Erk1 and Erk2 on threonine 202 and tyrosine
`204 in the activation loop of their kinase domain is required for full
`enzymatic activity of these proteins. Thus, the dual phosphoryla-
`tion of these sites is a measure of the enzymat

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket